# Pediatric Inflammatory Bowel Disease:  Developing Drugs for Treatment - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/pediatric-inflammatory-bowel-disease-developing-drugs-for-treatment/f199b979-79a2-47a4-99e4-b55e181a268d

> FDA guidance document: Pediatric Inflammatory Bowel Disease:  Developing Drugs for Treatment. Issue date: July 19, 2024. Get complete insights and analysis.

---

## Details

- Title: Pediatric Inflammatory Bowel Disease:  Developing Drugs for Treatment
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2024-07-19
- Comment Close Date: 2024-09-17
- Last Changed: 2024-07-25
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2024-D-2682">FDA-2024-D-2682</a>

## Related Documents

- [Erosive Esophagitis: Developing Drugs for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/erosive-esophagitis-developing-drugs-for-treatment/985e94e3-4616-49e9-822e-0854256bb10e)
- [Pediatric Gastroesophageal Reflux Disease: Developing Drugs for Treatment Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/pediatric-gastroesophageal-reflux-disease-developing-drugs-for-treatment-guidance-for-industry/eed3bedd-c895-4ca2-bd44-b1c92b786f14)
- [Crohn’s Disease:  Developing Drugs for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/crohns-disease-developing-drugs-for-treatment/10ab5c94-72ed-489d-b2cc-24cf6914fed5)